Cessation of anti-coagulation for bleeding and subsequent thrombosis events with a fully magnetically levitated centrifugal left ventricular assist device

J Heart Lung Transplant. 2019 Jul;38(7):788-789. doi: 10.1016/j.healun.2019.04.005. Epub 2019 Apr 29.

Authors

Igor Gosev¹, Brian Ayers², Katherine Wood², Bryan Barrus², Sunil Prasad²

Affiliations

¹ Division of Cardiac Surgery, University of Rochester Medical Center, Rochester, New York. Electronic address: [email protected].
² Division of Cardiac Surgery, University of Rochester Medical Center, Rochester, New York.

PMID: 31101370
DOI: 10.1016/j.healun.2019.04.005

No abstract available

Publication types

Letter

MeSH terms

Aged
Anticoagulants / administration & dosage*
Anticoagulants / adverse effects
Female
Heart-Assist Devices / adverse effects*
Hemorrhage / chemically induced*
Humans
Male
Middle Aged
Prosthesis Design
Retrospective Studies
Thrombosis / etiology*
Withholding Treatment

Substances

Anticoagulants